] . (2012). Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. Biol Blood Marrow Transplant, 18(9), 1368-77. presented at the 2012 Sep. doi:10.1016/j.bbmt.2012.02.002
. (2014). A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant, 20(3), 326-36. presented at the 2014 Mar. doi:10.1016/j.bbmt.2013.11.021